The Impact of Monotherapies for Male Androgenetic Alopecia: A Network Meta-Analysis Study

    May 2024 in “ Journal of cosmetic dermatology ”
    Aditya K. Gupta, Mary Bamimore, Tong Wang, Milton Talukder
    Studysummary The study concluded that dutasteride 0.5 mg daily for 24 weeks was the most effective monotherapy for increasing hair density in men with androgenetic alopecia, compared to other interventions.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 14

    1. The Comparative Effect of Monotherapies for Male Androgenetic Alopecia: A Protocol for Network Meta-Analysis Study 2024
    2. Topical Cetirizine for the Management of Androgenic Alopecia: Results of a Pilot Study Journal of Cosmetic Dermatology · 2023
    3. Relative Effects of Minoxidil 5%, Platelet-Rich Plasma, and Microneedling in Pattern Hair Loss: A Systematic Review and Network Meta-Analysis Skin appendage disorders · 2023
    4. Low-Dose Oral Minoxidil for Alopecia: A Comprehensive Review Skin appendage disorders · 2023
    5. Comparison of Oral Minoxidil, Finasteride, and Dutasteride for Treating Androgenetic Alopecia Journal of Dermatological Treatment · 2022
    6. Treatment of Androgenetic Alopecia Using PRP to Target Dysregulated Mechanisms and Pathways Frontiers in Medicine · 2022
    7. Relative Efficacy of Minoxidil and the 5-Alpha Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients JAMA Dermatology · 2022
    8. Finasteride for Hair Loss: A Review Journal of Dermatological Treatment · 2021
    9. Role of Low-Level Light Therapy in Androgenetic Alopecia Journal of Cutaneous and Aesthetic Surgery · 2021
    10. Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of Androgenetic Alopecia BioMed Research International · 2020
    11. Very-Low-Dose Oral Minoxidil in Male Androgenetic Alopecia: A Study with Quantitative Trichoscopic Documentation Journal of The American Academy of Dermatology · 2019
    12. Cosmetic Procedures in the Treatment of Alopecia InTech eBooks · 2017
    13. The Importance of Dual 5α-Reductase Inhibition in the Treatment of Male Pattern Hair Loss: Results of a Randomized Placebo-Controlled Study of Dutasteride Versus Finasteride Journal of The American Academy of Dermatology · 2006
    14. The Effects of Minoxidil, 1% Pyrithione Zinc, and a Combination of Both on Hair Density: A Randomized Controlled Trial British Journal of Dermatology · 2003

    Related research 9

    1. Minoxidil Sulfotransferase Enzymatical Activity in Plants: A Novel Paradigm in Increasing Minoxidil Response in Androgenetic Alopecia Journal of Cosmetic Dermatology · 2023
    2. Evaluation of Hair Regrowth After Minoxidil and Dutasteride Tattooing in Men with Androgenetic Alopecia JAAD international · 2023
    3. Combination Therapy with Oral Minoxidil and Dutasteride in the Treatment of Male Patterned Baldness: A Case Report Cosmoderma · 2022
    4. LB792 Minoxidil and Dutasteride Drug Tattooing for Male Androgenetic Alopecia Journal of Investigative Dermatology · 2021
    5. Tretinoin Enhances Minoxidil Response in Androgenetic Alopecia Patients by Upregulating Follicular Sulfotransferase Enzymes Dermatologic Therapy · 2019
    6. Mesotherapy with Dutasteride and Minoxidil in the Treatment of Androgenetic Alopecia Journal of The American Academy of Dermatology · 2018
    7. The Use of Minoxidil in the Treatment of Male and Female Androgenetic Alopecia: A Story of More Than 30 Years Italian journal of dermatology and venereology · 2018
    8. Retrospective Evaluation of the Application of Dutasteride, Unapproved by the FDA, for Male Pattern Baldness in Korea 한국임상약학회지 · 2015
    9. A Randomized Clinical Trial of 5% Topical Minoxidil Versus 2% Topical Minoxidil and Placebo in the Treatment of Androgenetic Alopecia in Men Journal of The American Academy of Dermatology · 2002